Jefferies Lifts Target on Covidien (COV), Staying Ahead of the Pack
Tweet Send to a Friend
Jefferies boosted its price target on Buy-rated Covidien Ltd (NYSE: COV) from $61 to $60 after the company's analyst day.
This article: 114 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 114 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
